Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis
Abstract Cancer stem cells (CSCs) are responsible for colorectal cancer (CRC) chemoresistance, recurrence, and metastasis. Therefore, identifying molecular stemness targets that are involved in tumor growth is crucial for effective treatment. Here, we performed an extensive in vitro and in vivo mole...
Saved in:
| Main Authors: | Martina Lepore Signorile, Elisabetta Di Nicola, Giovanna Forte, Paola Sanese, Candida Fasano, Vittoria Disciglio, Katia De Marco, Marialaura Latrofa, Loris De Cecco, Marica Ficorilli, Marta Lucchetta, Erica Torchia, Chiara Dossena, Giusy Bianco, Vito Spilotro, Claudia Ferroni, Nicoletta Labarile, Raffaele Armentano, Francesco Albano, Anna Mestice, Gianluigi Gigante, Valerio Lantone, Giuliano Lantone, Leonardo Vincenti, Alberto Del Rio, Greta Varchi, Valentina Grossi, Cristiano Simone |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-06-01
|
| Series: | Signal Transduction and Targeted Therapy |
| Online Access: | https://doi.org/10.1038/s41392-025-02290-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel regulation mechanism of histone methyltransferase SMYD5 in rheumatoid arthritis
by: Chenxi Xiao, et al.
Published: (2025-03-01) -
Identification of SMYD2 as a candidate diagnostic and prognostic biomarker for gastric cancer
by: Sichao Wang, et al.
Published: (2025-07-01) -
Small molecule compound ZYZ-384 targets SMYD3 to alleviate aging
by: Yang Liu, et al.
Published: (2025-07-01) -
SMYD2 inhibitors have no effect in improving non-alcoholic steatohepatitis in mice
by: Lanzexin Yang, et al.
Published: (2025-06-01) -
A Drosophila Smyd4 homologue is a muscle-specific transcriptional modulator involved in development.
by: Elizabeth C Thompson, et al.
Published: (2008-08-01)